Renalytix RNLXY
OTC RNLXY
$3.70 -0.09 (-2.37%)
At close: Nov 6, 2026 · 4:00 PM EST

Renalytix (RNLXY) EBIT (2020 - 2024)

Updated

Renalytix's EBIT was -$4.09 million in fiscal Q1 2025 (quarter ended Sep 30, 2024), compared with -$8.89 million a year earlier.

Analysis

Renalytix (RNLXY) EBIT (2020 - 2024) Analysis & Trends

On a trailing twelve-month basis, Renalytix's EBIT was -$24.81 million through Sep 30, 2024; for FY2024 (ended Jun 30, 2024), it came in at -$29.61 million.

  • In earlier fiscal years, EBIT was -$42.22 million in FY2023, -$53.18 million in FY2022, -$31.92 million in FY2021 and -$10.32 million in FY2020.
  • The fiscal Q1 2025 figure marks the highest quarterly EBIT in data going back to fiscal Q2 2021.
  • Per Business Quant data, RNLXY's EBIT in the three fiscal quarters before Q1 2025 was -$5.53 million (Q4 2024), -$6.55 million (Q3 2024) and -$8.64 million (Q2 2024).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 -4.09 Mn
Jun 30, 2024 -5.53 Mn
Mar 31, 2024 -6.55 Mn
Dec 31, 2023 -8.64 Mn
Sep 30, 2023 -8.89 Mn
Jun 30, 2023 -9.93 Mn
Mar 31, 2023 -10.92 Mn
Dec 31, 2022 -9.65 Mn
Sep 30, 2022 -11.72 Mn
Jun 30, 2022 -13.05 Mn
Mar 31, 2022 -14.54 Mn
Dec 31, 2021 -13.78 Mn
Sep 30, 2021 -11.81 Mn
Jun 30, 2021 -9.83 Mn
Mar 31, 2021 -8.07 Mn
Dec 31, 2020 -8.61 Mn
API Access

Renalytix EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=RNLXY&period=max&api_key=YOUR_API_KEY